Ambiguous lineage
Showing 1 - 25 of 210
Acute Leukemia of Ambiguous Lineage Trial in Suzhou (Venetoclax, azactidine)
Recruiting
- Acute Leukemia of Ambiguous Lineage
-
Suzhou, ChinaThe First Affliated Hospital of Soochow University
Jun 14, 2023
MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)
Recruiting
- Myelodysplastic Syndromes, de Novo
- +10 more
- Venetoclax
- +10 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 23, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 29, 2022
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ambiguous Lineage Leukemia or Lymphoma Trial in Washington, Atlanta,
Not yet recruiting
- Acute Lymphocytic Leukemia
- +3 more
-
Washington, District of Columbia
- +2 more
Feb 21, 2022
Acute Leukemia of Ambiguous Lineage Trial in Tianjin (vincristine, daunorubicin, cyclophosphamide)
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- vincristine
- +8 more
-
Tianjin, Tianjin, ChinaHBDH
Jun 17, 2020
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Total-Body Irradiation
- +8 more
-
Los Angeles, California
- +9 more
Aug 19, 2022
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,
Recruiting
- Acute Bilineal Leukemia
- +7 more
- Clofarabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia Trial in Atlanta, Seattle (Ex-Vivo Expanded Cord Blood Progenitor
Terminated
- Acute Leukemia of Ambiguous Lineage
- Acute Myeloid Leukemia
- Ex-Vivo Expanded Cord Blood Progenitor Cell Infusion
- +3 more
-
Atlanta, Georgia
- +1 more
Feb 27, 2019
The Myeloid Neoplasms Biology and Outcome Project
Recruiting
- Myeloid Neoplasm
-
Heidelberg, Baden-Württemberg, GermanyUHHeidelberg
Nov 21, 2022
Hematologic Malignancies Trial in Assiut (CD56)
Recruiting
- Hematologic Malignancies
- CD56
-
Assiut, Egypt
- +1 more
Jul 20, 2022
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow
Recruiting
- Inherited BMF Syndrome
- The whole-exome sequencing
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Jun 28, 2022
Optic Neuromyelitis Spectrum Disease Trial in China (BAT4406F Injection, BAT4406F Placebos)
Recruiting
- Optic Neuromyelitis Spectrum Disease
- BAT4406F Injection
- BAT4406F Placebos
-
Baotou, China
- +44 more
Sep 12, 2023
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)
Completed
- Relapsed/Refractory AML
- +5 more
- Plerixafor Dose Escalation
-
Phoenix, Arizona
- +8 more
Sep 5, 2018
Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients
Completed
- HIV Infections
- Leukemia
- (no location specified)
Apr 10, 2023
Radiation-Induced Mucositis Trial in Guangzhou (Steroid-eluting stent implantation, Steroid nasal spray, nasal saline rinses)
Recruiting
- Radiation-Induced Mucositis
- Steroid-eluting stent implantation
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Mar 3, 2023
Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase
Recruiting
- Lymphoblastic Leukemia
- +4 more
- Phase I
- Phase II
-
Singapore, SingaporeKK Women's and Children's hospital
Jun 20, 2022
Leukemia, T Cell Trial in Beijing (CD7 CART)
Recruiting
- Leukemia, T Cell
- CD7 CART
-
Beijing, Hebei, ChinaHe bei Yan da Lu dao pei Hospital
May 24, 2022
A Predictive Score System for AKI Following Pediatric Cardiac
Recruiting
- Congenital Heart Disease
- +2 more
- No intervention
-
Beijing, Beijing, ChinaFuwai Hospital
Aug 4, 2022
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide
Active, not recruiting
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Azacitidine
- +17 more
-
Birmingham, Alabama
- +173 more
Nov 16, 2021
Traumatic Knee Injury, Knee Trial (7 Tesla MRI)
Not yet recruiting
- Traumatic Knee Injury
- Knee
- 7 Tesla MRI
- (no location specified)
Jun 6, 2023